The new guideline is designed to present a clinical strategy for physicians. However, the guideline panel notes that the most effective approach for a specific case should be determined by the individual patient and their clinician.
In assessing patients, panel experts recommend a full basic assessment to identify characteristic IC/BPS symptoms and rule out confusable disorders; measurements of baseline voiding symptoms and pain levels; and consideration of cystoscopy and/or urodynamic studies to better assess patients or confirm a diagnosis.
The guideline also includes key clinical principles for first-line treatment of IC/BPS, including the use of the most conservative treatments before moving to less conservative therapies.
Read the news release about AUA’s Guideline on the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
Read other coverage about healthcare associations:
– OHA: 1 in 5 Patients Readmitted Within 30 Days
– AORN Urges Safety During Six Phases of Medication Administration Process